Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone H2B type 2-E is a basic structural protein encoded by the HIST2H2BE gene in humans and is a core component of nucleosomes, which organize eukaryotic chromosomal DNA into chromatin. It forms an octameric complex together with H2A, H3, and H4 histones to wrap DNA and regulate its accessibility. This protein is involved in the regulation of transcription, DNA replication, DNA repair, and maintenance of chromosomal stability. In addition to its structural roles, Histone H2B type 2-E has been reported to exhibit antimicrobial (antibacterial and antifungal) properties. Downregulation of the HIST2H2BE gene is associated with cervical cancer progression, suggesting possible relevance as a biomarker in oncology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone H2B type 2-E (H2BC21).